Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.100
-0.040 (-3.51%)
At close: Jun 3, 2026, 4:00 PM EDT
1.110
+0.010 (0.91%)
After-hours: Jun 3, 2026, 4:07 PM EDT
Invivyd Revenue
Invivyd had revenue of $13.74M in the quarter ending March 31, 2026, with 21.59% growth. This brings the company's revenue in the last twelve months to $55.87M, up 52.27% year-over-year. In the year 2025, Invivyd had annual revenue of $53.43M with 110.47% growth.
Revenue (ttm)
$55.87M
Revenue Growth
+52.27%
P/S Ratio
5.83
Revenue / Employee
$457,918
Employees
122
Market Cap
322.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.43M | 28.04M | 110.47% |
| Dec 31, 2024 | 25.38M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bicycle Therapeutics | 63.50M |
| Fennec Pharmaceuticals | 51.00M |
| Lineage Cell Therapeutics | 14.78M |
| Abeona Therapeutics | 14.54M |
| Fate Therapeutics | 6.32M |
| Silence Therapeutics | 839.00K |
IVVD News
- 9 hours ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 days ago - Invivyd completes enrollment in DECLARATION trial - TheFly
- 2 days ago - Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID - GlobeNewsWire
- 7 days ago - Invivyd to Participate in Upcoming Investor Events - GlobeNewsWire
- 15 days ago - Invivyd management to meet with BTIG - TheFly
- 15 days ago - Invivyd Transcript: AGM 2026 - Transcripts
- 20 days ago - Invivyd post earnings selloff overdone, says H.C. Wainwright - TheFly
- 20 days ago - Invivyd Earnings Call Transcript: Q1 2026 - Transcripts